Indeed, cAMP-degrading PDEs have been associated with several diseases in recent years, including stroke, acrodysostosis and COPD [9–14], and more recently, expression of a specific PDE4D isoform (PDE4D7) has been related to prostate cancer [15, 16]. Here, PDE4D is linked to prostate cancer.